ArticleAnnals of clinical and translational neurology2025

Factors for Rituximab Refractoriness in AQP4-IgG+ NMOSD: A Cohort Study.

Mariano Marrodan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.